Olema Pharmaceuticals Inc (OLMA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -134.332 | -253.659 | -13.994 | -22.264 | -40.965 | -39.244 |
Return on Equity (%) | 69.99 | 51.162 | -14.648 | -22.835 | -43.47 | -42.821 |
Return on Invested Capital (%) | -135.572 | -475.578 | -12.8 | -23 | -44.69 | -47.548 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 1.184 | -0.481 | 8.602 | 7.15 | 4.903 | 4.636 |
Earnings Per Share | -0.847 | -1.664 | -0.61 | -1.786 | -2.601 | -1.765 |
Cash Per Share | 1.214 | 0.026 | 8.613 | 0.347 | 0.588 | 1.251 |
Working Capital Per Share | 1.173 | -0.492 | 8.587 | 7.078 | 4.774 | 4.471 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.847 | -1.664 | -0.563 | -1.786 | -2.601 | -1.765 |
EBITDA Per Share | -0.847 | -1.664 | -0.563 | -1.786 | -2.601 | -1.765 |
Free Cash Flow Per Share | -0.85 | -1.668 | -0.609 | -1.751 | -2.601 | -1.772 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 2,59M | 2,59M | 39,31M | 39,8M | 40,29M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 40,29M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 340,92M |
Ratio cours/bénéfice | -3,65 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 5,14 |
Ratio prix/valeur comptable | 1,39 |
Rendement de dividende | - |
Actions en circulation | 57,3M |
Volume moyen (1 semaine) | 738,37k |
Volume moyen (1 mois) | 1,35M |
Variation sur 52 semaines | -44,80% |
Plus haut sur 52 semaines | 16,775 |
Plus bas sur 52 semaines | 4,60 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales